HIV MANAGEMENT PROGRAMME APPLICATION FORM

Similar documents
Chronic Benefit Application Form Cardiovascular Disease and Diabetes

Attending Physician Statement - Severe asthma

ENROLMENT FORM. Title: First Name: Surname: Postal Address: Postcode: Emergency Contact: Relationship: Phone: What is your main fitness goal?

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

Discovery HIVCare Programme

Quality of Life of HIV-infected Patients Study

Document Details. Patient Group Direction

HIVCare Programme 2017

(FIRST) (MIDDLE) (LAST) STREET: CITY: STATE: ZIP CODE:

Date: New Patient Form First Visit Date:

INITIATING ART IN CHILDREN: Follow the six steps

Gymnasium Sign In/Sign Out Sheet. Please sign in before commencing your workout

ACCESS TO PAIN MEDICATION QUESTIONNAIRE 2011, RESOLUTION 53/4

OCCUPATIONAL HEALTH PROTOCOL

AIDS and insurance. Information about the necessity of AIDS testing Implications of undergoing an AIDS test The choices available to you INSURANCE

SAMPLE OF PRE-COURSE OCCUPATIONAL HEALTH QUESTIONNAIRE 2017

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary

Autism Advisor Program NSW

Referral Form. Emmaus

Autism Advisor Program NSW

Initial Clinical History and Physical Form

NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Pro Active Physical Therapy & Sports Medicine

How to obtain vaccination records

HREC/17/RCHM/334 RCH HREC 37278A. ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank.

Member's Name RECOMMENDATION

Cystic Fibrosis Panel Applications (Dornase Alfa) Contents

Name Age Birthday / / Sex Last First MI. Home Address Street Apt City State Zip Code Home phone: ( ) Cell phone: ( ) Name of parent(s) or guardian:

OCCUPATIONAL HEALTH PROTOCOL

Important Information

Medical gap arrangements - practitioner application

Nursing and Midwifery students only. Section 1: Information

HIV Programme. Overview. About some of the terms we use in this document

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010

SHENANDOAH UNIVERSITY HEALTH FORM

IMMUNIZATION AND MEDICAL HISTORY FORM

MODIFICATION OF APPLICATION TO BECOME A LICENSED PRODUCER UNDER THE ACCESS TO CANNABIS FOR MEDICAL PURPOSES REGULATIONS

PATIENT SIGNATURE: DOB: Date:

medical monitoring: clinical monitoring and laboratory tests

PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

Please everything to the address below: ITEMS TO MAIL. 1. Copy of the athletes immunization record

ASTHMA OR ANAPHYLAXIS MEDICAL MANAGEMENT PLAN I. CONTACT AND PLAN INFORMATION

THE COLLEGES OF MEDICINE OF SOUTH AFRICA Incorporated Association not for gain Reg No/Nr 1955/000003/08

Student Health Services

Patient information. Today s Date. Patient s Name D.O.B. Street Address Apt. No. Home Phone # Work Phone # Social Security # DL # State

Vassar College 124 Raymond Avenue Box 17 Poughkeepsie New York Please contact us at for any questions/concerns.

Following this letter are health forms for parents or legal guardians to complete and sign. Please note that:

Patient Name: Nickname: Date of Birth: Age: Sex: Male Female Address: City : Zip: School: Grade: Previous Dentist & Address: Pediatrician & Address:

DAY1 HEALTH CHRONIC MEDICATION BENEFIT APPLICATION FORM

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM

Drug Prior Authorization Form Opdivo (nivolumab)

MEDICAL AND PERSONAL HISTORY

MEMBER SHARE A Pastoral Medical Association - Private Membership Program MEMBER SHARE AGREEMENT (MSA)

The Johns Hopkins Bloomberg School of Public Health

REFERRAL SOURCE GUIDELINES. Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre.

Athlete Consent Form:

Enrollment Application

History & Review of Systems Screening. Medical History

New Patient Information

Feidhmeannacht na Seirbhíse Sláinte

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

WELD COUNTY ADULT TREATMENT COURT REFERRAL INFORMATION

Ophthalmologist/Optometrist/Low Vision Clinic Report. 1.1 Title: (Mr/Mrs/Miss, etc) Surname: Full Names:. 1.4 Physical Address:.

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions

Document Details. Patient Group Direction

Home Phone Cell Phone

Medical Declaration Form. Important information to read before completing the form:

/ / 002. District name:

19 TH JUDICIAL DUI COURT REFERRAL INFORMATION

Mental Health Commission Rules

APPLICATION FORM PILOT STUDY OF OMEGA-3 AND VITAMIN D IN T1D

PLEASE COMPLETE ALL RELEVANT SECTIONS OF THIS FORM

NIIM HREC: TGA AUTHORISED PRESCRIBER SCHEME APPLICATION APPROVAL PROCEDURES 1. Procedures Statement

Washington County-Johnson City Health Department Christen Minnick, MPH, Director 219 Princeton Road Johnson City, Tennessee Phone:

GARDEN STATE SLEEP CENTER REGISTRATION FORM PATIENT INFORMATION:

Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules

Patient Name: First MI Last Preferred Name. DOB: Sex: MALE FEMALE SSN: Address: City: State: Zip Code:

Demographics. HIV Testing

THIS FORM IS TO BE COMPLETED BY CANDIDATE.

Drug Prior Authorization Form Alertec (modafinil)

OPTIMA COLLEGE CONTACT CENTRE SUPPORT APPLICATION FORM

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

HEALTH EXAMINATION GUIDELINES FOR ENTRY INTO MALAYSIAN HIGHER EDUCATIONAL INSTITUTIONS

Moms Help Organization Helping Moms to be the best Moms they can be! West Sample Road, #24 Coral Springs, FL

This page is for information. Do not submit.

Dental Health Certificate

Withdrawing your consent

HEALTH EXAMINATION GUIDELINES FOR ENTRY INTO MALAYSIAN HIGHER EDUCATIONAL INSTITUTIONS

REGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY A Pharmacist s Guide

Membership Package Checklist

Personal Information Protection Act Consent Form

MEDICAL AND PERSONAL HISTORY

Transcription:

Private Private Bag X82081, Bag X82081, Rustenburg, Rustenburg, 0300 0300 Tel: Tel: (014) 590 5901700 1900 Fax: Fax: 086 (014) 577 0274 591 4570 www.platinumhealth.co.za www.platinumhealth.co.za ZZGPlatinumHealthClinicalMotivation@angloamerican.com zzgplatinumhealthclinicalmotivation@angloplat.com HIV MANAGEMENT PROGRAMME APPLICATION FORM 1. Please complete the HIV management programme application form in PRINT with black ink and forward to Platinum Health. 2. Relevant test results must be attached. 3. Failure to provide all information, will result in unnecessary delays. 1 PATIENT INFORMATION (Please complete in full) Patient dependant code: Title: Prof Dr Mr Ms Initials: Surname: Names in full (as per identity document): Date of birth: C C Y Y M M D D E-mail: Tel no (Home): Tel no (Work): Cell no: Sex: Male Female The outcome of this application must be communicated to me via Email SMS Other doctors or specialists (that you are seeing in addition to the doctor filling in this form): Name: Tel no (Practice): Speciality: 2 DECLARATION I hereby apply for the HIV DISEASE MANAGEMENT PROGRAMME and agree that I will be bound by the Rules of the Scheme as amended from time to time. I warrant that the information in this application is complete and correct. I understand that all personal clinical information supplied to Platinum Health will be used to determine access to specific benefits regarding the HIV DISEASE MANAGEMENT PROGRAMME. The programme s medical staff will review this information in order to make recommendations regarding the provision of these benefits. I understand that acceptance onto the HIV DISEASE MANAGEMENT PROGRAMME means that a treatment support counsellor will contact me. Patient Parent/Guardian (If the patient is a minor, parent, legal guardian or custodian must sign the form.) Date: C C Y Y M M D D Page 1 of 6

3 DOCTOR WHO WILL PROVIDE ONGOING CARE (to be completed by the doctor) Name: Date: C C Y Y M M D D Speciality: Tel no (Home): Fax no: E-mail: Qualifying degree: BHF Practice number: HPCSA/MP number: 4 CLINICAL HISTORY (current diagnosis and medication recorded under section 6) When was HIV infection first diagnosed? (Please attach report): C C Y Y M M D D Is the patient currently being treated for tuberculosis? Yes No If YES, please specify the treatment start date: C C Y Y M M D D Has the patient previously been exposed to antiretrovirals? Yes (MTCT prophylaxis) Yes (other) No If YES, please provide details below: PREVIOUS ANTIRETROVIRAL EXPOSURE NOTE: IF THE APPLICATION IS FOR A BABY, PLEASE LIST THE MOTHER S PREVIOUS ART HISTORY. DRUGS DATE TREATMENT STARTED DATE TREATMENT ENDED TREATMENT DURATION (MONTHS) REASON FOR DISCONTINUATION Current combination the patient is taking: Please list all other medication the patient is taking, including prophylaxis: Is the patient allergic to any medication? Yes No Is the patient allergic to sulphonamides? Yes No Does the patient have any other allergies? Yes No If YES, please specify: Is there a history of depression or psychiatric illness? Yes No If YES, please specify treatment: Is there a history of heavy alcohol intake? (More than four drinks per day for a long period of time) Yes No Is there a history of recreational drug use? (Cannabis, Cocaine, Ecstasy, LSD etc.) Yes No Page 2 of 6

5 CLINICAL EXAMINATION (to be completed by the doctor) Female patients Is the patient pregnant? Yes No If YES, expected date of delivery: C C Y Y M M D D Expected mode of delivery: NVD C/S Expected date of C/S: C C Y Y M M D D Please specify in Section 6 whether I/V or oral medicines are preferred during labour. Patient weight in kilogram: Patient height in metres: WHO CLINICAL STAGING: Adult / Adolescent Clinical stage 1: (Please tick) Generalised lymphadenopathy Clinical stage 2: (Please tick) Weight loss, <10% of body weight Recurrent upper respiratory tract infections Clinical stage 3: (Please tick) Weight loss (= kg), >10% of body weight Oral hairy leukoplakia Clinical stage 4: (Please tick) Unexplained chronic diarrhoea >1 month Pulmonary tuberculosis Oral candidiasis Severe bacterial infections (i.e. pneumonia) HIV wasting syndrome Paediatric Clinical stage 1: (Please tick) Generalised lymphadenopathy Clinical stage 2: (Please tick) Unexplained chronic diarrhoea Recurrent severe bacterial infections Persistent Fever Weight loss or failure to thrive Severe persistent or recurrent candidiasis outside the neonatal period Clinical stage 3: (Please tick) Severe failure to thrive Progressive encephalopathy Recurrent septicaemia or meningitis Malignancy Is there any degree of peripheral neuropathy? Yes No If YES, please specify: Mild Moderate Severe Is there any other significant clinical finding? Yes No If YES, please specify: Page 3 of 6

6 SPECIAL INVESTIGATIONS RESULTS (provide copies of all reports and as many as possible) DATE THAT TEST WAS PERFORMED VIRAL LOAD (copies / ml) ADDITIONAL INVESTIGATIONS WERE TESTS PERFORMED? Haemoglobin U & E ALT Cholesterol (Total) Tuberculin skin test (TST) IF YES, PLEASE SPECIFY THE RESULTS DATE TESTS WERE PERFORMED 7 MEDICATION NOTE TO MEMBER AND DOCTOR: PLEASE NOTE THAT GENERIC EQUIVALENTS WILL BE DISPENSED AS PER FORMULARY. ANTIRETROVIRAL THERAPY STRENGTH (e.g. 10mg) DIRECTIONS (e.g. 1 tds) PERIOD IN USE (MONTHS) PERIOD REQUIRED (MONTHS) Other Medication Required (associated with the management of HIV) DESCRIPTION OF DIAGNOSIS DATE OF FIRST DIAGNOSIS MEDICATION NAME, STRENGTH AND DOSAGE HOW LONG HAS THE PATIENT USED THIS MEDICATION? MAY A GENERIC BE USED? YEARS MONTHS 8 Name: DOCTOR S DETAILS AND SIGNATURE (to be completed by the doctor) Date: C C Y Y M M D D Speciality: Tel no (Practice): Doctor s Page 4 of 6

SOCIAL WORKER ASSESSMENT PSYCHOLOGIST ASSESSMENT Page 5 of 6

DECLARATION BY PATIENT 1. I understand that the information contained in this application for enrolment in Platinum Health s HIV Programme will be treated with complete confidentiality and sensitivity. I also understand that although every care is taken to keep my HIV status completely confidential, Platinum Health has no control over any conclusions my dependants may draw regarding my HIV status during the normal claims process. 2. I understand that Platinum Health needs to access my personal clinical information to make recommendations regarding my chronic medication needs and to provide me with the full benefits of the Platinum Health HIV Programme. I therefore authorize any third party, disease management, previous scheme or health care professional e.g. pathology, laboratories, doctors, hospitals, etc, in possession of any medical information regarding my dependants (if minor) or myself, to provide Platinum Health with any information, that they may require, with the exception of any information that I stipulate in writing may not be provided to Platinum Health. I acknowledge that my medical service provider retains responsibility for my diagnosis and treatment. 3. I am aware that I am HIV-positive. 4. I understand that, at this stage, HIV infection can be treated with antiretroviral therapy, but that there is no cure available as yet. 5. I understand that if I am eligible for antiretroviral therapy, I will be required to take all the medication prescribed to me as directed and that I cannot skip doses of my medication. If I should require assistance with taking my medication or find that the medication makes me unwell, I will know that I can contact my medical practitioner and/or Platinum Health to assist me. 6. Cover for ART is subject to national antiretroviral treatment guidelines, clinical entry criteria and pre-authorisation. 7. I understand that once I have registered on the programme, there will be no limit on HIV-related hospital admissions, subject to my option type and sub-limits. However, if I don t comply with the Platinum Health HIV Programme, I acknowledge that Platinum Health reserves the right to review my further participation in the programme. If my participation on the programme is terminated as a result of my failure to comply with the programme, my entitlement to such benefits may be reviewed. 8. I consent to Platinum Health disclosing to such pharmacies and contracted providers of disease management programmes such information of mine as is necessary to ensure that I receive the full benefits of the Platinum Health HIV Programme. I understand that such pharmacies and providers are bound by obligations of confidentiality. 9. I understand that Platinum Health will facilitate admissions to the most appropriate facility in consultation with me and my treating doctor. 10. I understand the consequences of not taking ART as it has been explained to me. I understand I have a right to decline or accept ART. ACCEPT DECLINE OR (please mark with a X) Patient Parent/Guardian (If the patient is a minor, parent, legal guardian or custodian must sign the form.) Date: C C Y Y M M D D Page 6 of 6